CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

Trial run: FDA launches pilot for expedited INDs

RegulatoryPositive
AI Analysis

Summary

The FDA has launched a pilot program for expedited INDs as part of Operation Trialblazer, which experts view as a beneficial regulatory development for clinical trial advancement.

Importance:4/10
Sentiment:
0.60
FDAINDExpedited ReviewOperation TrialblazerRegulatory

Read the original article

Published by Clinical Trials Arena on September 15, 2026 4:30 PM

Read Original